Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Advertising & Marketing

Sales

Legal & Regulatory

Acquisition & Integration

Goodwill impairment

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Teladoc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Teladoc reports solid Q4 growth, eyes revenue optimization strategies

Teladoc's Q4 performance showed revenue growth and margin focus, with BetterHelp contributing significantly to profitability.
The company's strategic focus on virtual care expansion and revenue optimization positions Teladoc for continued success in the healthcare market.
While facing internal restructuring challenges, Teladoc's emphasis on growth drivers and operational efficiency presents opportunities for future growth and market leadership.

Teladoc Health excels in Q1, eyes growth and efficiency

Teladoc Health's Q1 performance was strong, with revenue exceeding expectations.
The company is focused on efficiency, innovation, and driving value in virtual care.
BetterHelp segment showed growth and stability, with improving margins expected.
Opportunities exist to capitalize on ad pricing stability and consumer behavior trends.

Teladoc surpasses revenue expectations, focuses on innovation and growth

Teladoc's Q2 performance exceeded expectations, with strong revenue growth and improved margins in both segments. The company's strategic focus on whole-person care, weight management, and AI enhancements positions it well for future growth. Challenges include managing drug costs and private company valuations, while opportunities lie in virtual care demand and strategic M&A.
Teladoc's financial strength, commitment to innovation, and focus on efficiency improvements are key strengths driving its performance. The company's ability to navigate challenges and capitalize on opportunities in the evolving healthcare landscape underscores its resilience and growth potential.

Teladoc Health surpasses Q3 expectations, eyes margin expansion in '24

Teladoc Health's Q3 performance exceeded expectations, driven by revenue growth and margin improvements.
The company is focused on enhancing cost efficiencies, profitability, and driving margin expansion.
Stable pricing environment and strong client demand present opportunities for future growth.
Operational review and strategic initiatives position Teladoc for continued success in the healthcare sector.

Teladoc reports robust 2023 earnings, eyes growth amid marketing challenges

Teladoc delivered strong financial performance in 2023 with notable growth in adjusted EBITDA and revenue. The company faces challenges in BetterHelp marketing yields and delayed consumer engagement efforts.
However, Teladoc's strategic strengths lie in its long-term outlook for revenue growth, margin expansion, and cost-saving initiatives. Opportunities exist in optimizing sales force structure and capital deployment for future growth.
Overall, Teladoc's focus on profitability, growth optimization, and strategic capital allocation positions it well for sustained success in the telehealth industry.

Teladoc Health reports solid Q1 performance amidst revenue challenges

Teladoc Health's Q1 2024 performance showcased revenue growth in Integrated Care but challenges in BetterHelp segment revenue and margin management.
The company's financial strength, product portfolio, and cost initiatives position it well for growth opportunities and strategic market positioning.
Addressing challenges in ad spend management and focusing on international market efficiency are key to unlocking growth potential and improving financial performance.
Overall, Teladoc's performance, strengths, challenges, and opportunities reflect a dynamic landscape with strategic focus on sustainable growth and operational efficiency.

Teladoc Health reports Q2 revenue dip, EBITDA growth; addresses challenges

Teladoc Health's Q2 2024 performance showed mixed results with revenue decline but EBITDA growth. The company is leveraging strengths in patient safety and technology while addressing challenges in customer acquisition costs. Opportunities lie in operational efficiency, insurance coverage access, and international expansion.

Teladoc Health reports Q3 revenue decline but strategic growth

Teladoc Health's Q3 2024 performance reflects mixed results with revenue decline but strategic growth in the Integrated Care segment.
The company's focus on customer-centric strategies, technology, and clinical excellence positions it well for future success and market leadership.
Challenges in revenue decline and expense management require Teladoc Health to balance short-term financial performance with long-term growth objectives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

AppHarvest

DraftKings

Rada Electronic

Riot Blockchain

TuSimple Holdings

These seven growth stocks are trading at a discount after the recent market correction and can provide big returns in the next 12-24 months. The post 7 Growth Stocks Trading at a Huge Discount Right Now appeared first on InvestorPlace.

7 Growth Stocks Trading at a Huge Discount Right Now

NEW YORK , July 22, 2022 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Teladoc Health, Inc. (NYSE: TDOC) between October 28, 2021 and April 27, 2022, both dates inclusive (the "Class Period"), of the important August 5, 2022 lead plaintiff deadline. SO WHAT: If you purchased Teladoc Health securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, A LEADING LAW FIRM, Encourages Teladoc Health, Inc. Investors with Losses to Secure Counsel Before Important August 5 Deadline in Securities Class Action - TDOC

NEW ORLEANS , July 22, 2022 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 5, 2022 to file lead plaintiff applications in a securities class action lawsuit against Teladoc Health, Inc. (NYSE: TDOC), if they purchased the Company's securities between October 28, 2021 and April 27, 2022, inclusive (the "Class Period").

TELADOC HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teladoc Health, Inc. - TDOC

Shopify

These stocks are both down more than 50% this year.

2 Beaten Down Stocks That Could Rally in the Second Half of 2022

Amazon expanding its presence in the telehealth market sent the stock crashing down.

Why Teladoc Stock Crashed on Thursday but Immediately Recovered

Teladoc (TDOC) stock is on the move today as investors in the company react to news of Amazon (AMZN) acquiring One Medical (ONEM). The post What Is Going on With Teladoc (TDOC) Stock Today?

What Is Going on With Teladoc (TDOC) Stock Today?

Amazon's big deal gives Teladoc shareholders a scare.

Why Teladoc Shares Are Falling Today

New York, New York--(Newsfile Corp. - July 21, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Teladoc Health, Inc. (NYSE: TDOC) between October 28, 2021 and April 27, 2022, both dates inclusive (the "Class Period"), of the important August 5, 2022 lead plaintiff deadline.SO WHAT: If you purchased Teladoc Health securities during the Class Period you may be entitled to compensation without payment of any...

TDOC FINAL DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Teladoc Health, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important August 5 Deadline in Securities Class Action - TDOC

Shares of Teladoc Health, Inc. (NYSE: TDOC) are trading lower today after Amazon.com, Inc. (NASDAQ: AMZN) announced the acquisition of One Medical (NASDAQ: ONEM) in an all cash deal, which has weighed on other telemedicine and digital health competitors.  What Happened?

Why Are Shares of Teladoc Health Down Today?

New York, New York--(Newsfile Corp. - July 19, 2022) - Pomerantz LLP announces that a class action lawsuit has been filed against Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE: TDOC) and certain of its officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 22-cv-04687, is on behalf of a class consisting of all persons and entities other than Defendants that...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Teladoc Health, Inc. of Class Action Lawsuit and Upcoming Deadline - TDOC

Doximity

Humana

The best telehealth stocks are undervalued after an abrupt sell-off. There are a few names such as TDOC, DOCS and HUM that stand out.

3 Best Telehealth Stocks To Buy Now

New York, New York--(Newsfile Corp. - July 18, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Teladoc Health, Inc. (NYSE: TDOC) between October 28, 2021 and April 27, 2022, both dates inclusive (the "Class Period"), of the important August 5, 2022 lead plaintiff deadline.SO WHAT: If you purchased Teladoc Health securities during the Class Period you may be entitled to compensation without payment of any...

ROSEN, Global Investor Counsel, Encourages Teladoc Health, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TDOC

San Diego, California--(Newsfile Corp. - July 18, 2022) - Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE: TDOC). The class action is on behalf of shareholders who purchased Teladoc securities between October 28, 2021 and April 27, 2022, both dates inclusive (the "Class Period"). Investors are hereby notified that they have until August 5, 2022...

TDOC Class Action Complaint Filed: Johnson Fistel, Globally-Recognized Law Firm Encourages Shareholders to Submit Their Losses

Pinterest

How will these companies' next earnings reports affect their prospects?

2 Stocks That Have a Lot to Prove This Earnings Season

NEW YORK , July 16, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Teladoc Health, Inc. (NYSE: TDOC) between October 28, 2021 and April 27, 2022, both dates inclusive (the "Class Period"), of the important August 5, 2022 lead plaintiff deadline. SO WHAT: If you purchased Teladoc Health securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Teladoc Health, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TDOC

Latest clinical data underscores the value and impact of whole person care Latest clinical data underscores the value and impact of whole person care

New Data Shows Teladoc Health's Integrated Chronic Care Solutions Deliver Improved Health Outcomes

New York, New York--(Newsfile Corp. - July 13, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Teladoc Health, Inc. (NYSE: TDOC) between October 28, 2021 and April 27, 2022, both dates inclusive (the "Class Period"), of the important August 5, 2022 lead plaintiff deadline.SO WHAT: If you purchased Teladoc Health securities during the Class Period you may be entitled to compensation without payment of any...

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Teladoc Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TDOC

Teladoc has failed to recover from the guidance shock in 1Q-22. Sales growth slowed at a scary pace in 1Q-22, suggesting that guidance risks have increased.

Teladoc: Harsh Reality Check Is Upon Investors

The telehealth company reports earnings later this month.

3 Burning Questions I Have for Teladoc

Amazon

DoorDash

Alphabet

Tesla

Zoom Video

Growth stocks have been all the rage ever since the stock market began its recovery from the financial crisis. However, it was not until the Covid-19 pandemic hit that this dubiously named and loosely defined chunk of the market was catapulted into bubble status.

The 2nd Tech Bubble Has Burst: Where Will Growth Stocks Go From Here?

A disappointing second-quarter report helped lead to the stock plunge.

Why Teladoc Health Lost 64% in the First Half of the Year

PURCHASE, NY, July 12, 2022 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release second quarter 2022 results on Wednesday, July 27, 2022, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.

Teladoc Health to Announce Second Quarter 2022 Financial Results

On July 10, Bank of America Corp (NYSE: BAC) analyst Allen Lutz published an analyst note on Teladoc Health, Inc (NYSE: TDOC). What Happened: The Bank of America analyst had a Neutral rating on Teladoc with a $42 price objective.

Why Do Teladoc Health Investors Stand Divided? Bank Of America Analyst Weighs In

NEW ORLEANS , July 8, 2022 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 5, 2022 to file lead plaintiff applications in a securities class action lawsuit against Teladoc Health, Inc. (NYSE: TDOC), if they purchased the Company's securities between October 28, 2021 and April 27, 2022, inclusive (the "Class Period").

TELADOC HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teladoc Health, Inc. - TDOC

Did you lose money on investments in Teladoc Health? If so, please visit Teladoc Health, Inc. Shareholder Class Action Lawsuit or contact  Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.

TELADOC HEALTH, INC. (NYSE: TDOC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Teladoc Health, Inc. (NYSE: TDOC)

News for Teladoc Stock (TDOC)